{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:19:43Z","timestamp":1776259183942,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11934-016-0622-2","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T07:54:34Z","timestamp":1468828474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Peyronie\u2019s Disease: Intralesional Therapy and Surgical Intervention"],"prefix":"10.1007","volume":"17","author":[{"given":"Louis A.","family":"Aliperti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"issue":"5","key":"622_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","volume":"14","author":"F Sommer","year":"2002","unstructured":"Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, et al. Epidemiology of Peyronie\u2019s disease. Int J Impot Res. 2002;14(5):379\u201383. doi: 10.1038\/sj.ijir.3900863 .","journal-title":"Int J Impot Res"},{"issue":"5","key":"622_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.ijir.3900727","volume":"13","author":"EL Rhoden","year":"2001","unstructured":"Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodosio da Ros C, Ary Vargas Souto C. Prevalence of Peyronie\u2019s disease in men over 50-y-old from Southern Brazil. Int J Impot Res. 2001;13(5):291\u20133.","journal-title":"Int J Impot Res"},{"issue":"7","key":"622_CR3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int. 2001;88(7):727\u201330.","journal-title":"BJU Int"},{"issue":"6 Pt 1","key":"622_CR4","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, et al. Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171(6 Pt 1):2350\u20133.","journal-title":"J Urol"},{"issue":"3","key":"622_CR5","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/01.ju.0000170231.51306.32","volume":"174","author":"AI El-Sakka","year":"2005","unstructured":"El-Sakka AI, Tayeb KA. Peyronie\u2019s disease in diabetic patients being screened for erectile dysfunction. J Urol. 2005;174(3):1026\u201330. doi: 10.1097\/01.ju.0000170231.51306.32 .","journal-title":"J Urol"},{"issue":"3","key":"622_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","volume":"7","author":"R Tal","year":"2010","unstructured":"Tal R, Heck M, Teloken P, Siegrist T, Nelson CJ, Mulhall JP. Peyronie\u2019s disease following radical prostatectomy: incidence and predictors. J Sex Med. 2010;7(3):1254\u201361. doi: 10.1111\/j.1743-6109.2009.01655.x .","journal-title":"J Sex Med"},{"issue":"4","key":"622_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ijir.2011.18","volume":"23","author":"HM Nugteren","year":"2011","unstructured":"Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. The association between Peyronie\u2019s and Dupuytren\u2019s disease. Int J Impot Res. 2011;23(4):142\u20135. doi: 10.1038\/ijir.2011.18 .","journal-title":"Int J Impot Res"},{"issue":"1","key":"622_CR8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","volume":"157","author":"CJ Devine Jr","year":"1997","unstructured":"Devine Jr CJ, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie\u2019s lesion. J Urol. 1997;157(1):285\u201390.","journal-title":"J Urol"},{"issue":"5","key":"622_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1464-410X.2008.07738.x","volume":"102","author":"R Tal","year":"2008","unstructured":"Tal R, Mulhall JP. Intracavernosal injections and fibrosis: myth or reality? BJU Int. 2008;102(5):525\u20136. doi: 10.1111\/j.1464-410X.2008.07738.x .","journal-title":"BJU Int"},{"issue":"6","key":"622_CR10","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie\u2019s disease. J Urol. 2006;175(6):2115\u20138. doi: 10.1016\/S0022-5347(06)00270-9 . discussion 8.","journal-title":"J Urol"},{"issue":"4","key":"622_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ucl.2005.08.011","volume":"32","author":"JM Greenfield","year":"2005","unstructured":"Greenfield JM, Levine LA. Peyronie\u2019s disease: etiology, epidemiology and medical treatment. Urol Clin North Am. 2005;32(4):469\u201378. doi: 10.1016\/j.ucl.2005.08.011 . vii.","journal-title":"Urol Clin North Am"},{"issue":"4","key":"622_CR12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol. 1997;158(4):1391\u20134.","journal-title":"J Urol"},{"issue":"6 Suppl","key":"622_CR13","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1111\/1523-1747.ep12874789","volume":"95","author":"RD Granstein","year":"1990","unstructured":"Granstein RD, Flotte TJ, Amento EP. Interferons and collagen production. J Invest Dermatol. 1990;95(6 Suppl):75S\u201380S.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"622_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/00365599109024539","volume":"25","author":"MR Duncan","year":"1991","unstructured":"Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie\u2019s disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol. 1991;25(2):89\u201394. doi: 10.3109\/00365599109024539 .","journal-title":"Scand J Urol Nephrol"},{"issue":"4","key":"622_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.ijir.3900414","volume":"11","author":"SK Ahuja","year":"1999","unstructured":"Ahuja SK, Sikka SC, Hellstrom WJ. Stimulation of collagen production in an in vitro model for Peyronie\u2019s disease. Int J Impot Res. 1999;11(4):207\u201312.","journal-title":"Int J Impot Res"},{"issue":"1","key":"622_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","volume":"176","author":"WJ Hellstrom","year":"2006","unstructured":"Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie\u2019s disease. J Urol. 2006;176(1):394\u20138. doi: 10.1016\/S0022-5347(06)00517-9 . Extremely important reference: This is the only randomized placebo controlled trial testing intralesional interferon administration.","journal-title":"J Urol"},{"issue":"5","key":"622_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.ijir.3900867","volume":"14","author":"GL Lacy 2nd","year":"2002","unstructured":"Lacy 2nd GL, Adams DM, Hellstrom WJ. Intralesional interferon-alpha-2b for the treatment of Peyronie\u2019s disease. Int J Impot Res. 2002;14(5):336\u20139. doi: 10.1038\/sj.ijir.3900867 .","journal-title":"Int J Impot Res"},{"issue":"4721","key":"622_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1126\/science.2994224","volume":"230","author":"RB Kelly","year":"1985","unstructured":"Kelly RB. Pathways of protein secretion in eukaryotes. Science. 1985;230(4721):25\u201332.","journal-title":"Science"},{"issue":"6","key":"622_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0010-4809(88)90011-0","volume":"21","author":"DB Askey","year":"1988","unstructured":"Askey DB, Herman IM. Computer-assisted analysis of the vascular endothelial cell motile response to injury. Comput Biomed Res. 1988;21(6):551\u201361.","journal-title":"Comput Biomed Res"},{"issue":"5","key":"622_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.ijir.3900917","volume":"14","author":"LA Levine","year":"2002","unstructured":"Levine LA, Estrada CR. Intralesional verapamil for the treatment of Peyronie\u2019s disease: a review. Int J Impot Res. 2002;14(5):324\u20138. doi: 10.1038\/sj.ijir.3900917 .","journal-title":"Int J Impot Res"},{"issue":"4","key":"622_CR21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","volume":"51","author":"J Rehman","year":"1998","unstructured":"Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie\u2019s disease plaque: a long-term single-blind study. Urology. 1998;51(4):620\u20136.","journal-title":"Urology"},{"issue":"2","key":"622_CR22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","volume":"168","author":"LA Levine","year":"2002","unstructured":"Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie\u2019s disease. J Urol. 2002;168(2):621\u20135. discussion 5\u20136.","journal-title":"J Urol"},{"issue":"6","key":"622_CR23","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","volume":"151","author":"LA Levine","year":"1994","unstructured":"Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie\u2019s disease. J Urol. 1994;151(6):1522\u20134.","journal-title":"J Urol"},{"issue":"3","key":"622_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","volume":"41","author":"M Shirazi","year":"2009","unstructured":"Shirazi M, Haghpanah AR, Badiee M, Afrasiabi MA, Haghpanah S. Effect of intralesional verapamil for treatment of Peyronie\u2019s disease: a randomized single-blind, placebo-controlled study. Int Urol Nephrol. 2009;41(3):467\u201371. doi: 10.1007\/s11255-009-9522-4 .","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"622_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","volume":"5","author":"LA Levine","year":"2008","unstructured":"Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie\u2019s disease: a single-center pilot study. J Sex Med. 2008;5(6):1468\u201373. doi: 10.1111\/j.1743-6109.2008.00814.x .","journal-title":"J Sex Med"},{"issue":"12","key":"622_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s40265-015-0441-7","volume":"75","author":"S Dhillon","year":"2015","unstructured":"Dhillon S. Collagenase clostridium histolyticum: a review in Peyronie\u2019s disease. Drugs. 2015;75(12):1405\u201312. doi: 10.1007\/s40265-015-0441-7 .","journal-title":"Drugs"},{"issue":"1","key":"622_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199\u2013207. doi: 10.1016\/j.juro.2013.01.087 . Extremely important reference: This is the phase 3 trial data for which FDA approval for Xiaflex was granted.","journal-title":"J Urol"},{"key":"622_CR28","unstructured":"Inc. AP. US Prescribing Information. Auxilium Pharmaceuticals Inc. 2015. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/125338s085s087s088lbl.pdf . Accessed 5\/21\/16 2016."},{"issue":"3","key":"622_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194(3):745\u201353. doi: 10.1016\/j.juro.2015.05.098 .","journal-title":"J Urol"},{"issue":"5","key":"622_CR30","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bju.13120","volume":"116","author":"CC Carson 3rd","year":"2015","unstructured":"Carson 3rd CC, Sadeghi-Nejad H, Tursi JP, Smith TM, Kaufman GJ, Gilbert K, et al. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie\u2019s disease (PD). BJU Int. 2015;116(5):815\u201322. doi: 10.1111\/bju.13120 .","journal-title":"BJU Int"},{"issue":"6","key":"622_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1756287212448224","volume":"4","author":"EM Mobley","year":"2012","unstructured":"Mobley EM, Fuchs ME, Myers JB, Brant WO. Update on plication procedures for Peyronie\u2019s disease and other penile deformities. Adv Urol. 2012;4(6):335\u201346. doi: 10.1177\/1756287212448224 .","journal-title":"Adv Urol"},{"issue":"5","key":"622_CR32","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/S0022-5347(05)65085-9","volume":"167","author":"SS Gholami","year":"2002","unstructured":"Gholami SS, Lue TF. Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol. 2002;167(5):2066\u20139.","journal-title":"J Urol"},{"issue":"4","key":"622_CR33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(01)66862-9","volume":"154","author":"DJ Ralph","year":"1995","unstructured":"Ralph DJ, Al-kraa M, Pryor JP. The Nesbit operation for Peyronie\u2019s disease: 16-year experience. J Urol. 1995;154(4):1362\u20133.","journal-title":"J Urol"},{"issue":"1","key":"622_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","volume":"10","author":"LA Levine","year":"2013","unstructured":"Levine LA, Burnett AL. Standard operating procedures for Peyronie\u2019s disease. J Sex Med. 2013;10(1):230\u201344. doi: 10.1111\/j.1743-6109.2012.03003.x .","journal-title":"J Sex Med"},{"issue":"4","key":"622_CR35","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0022-5347(01)66891-5","volume":"154","author":"MK Gelbard","year":"1995","unstructured":"Gelbard MK. Relaxing incisions in the correction of penile deformity due to Peyronie\u2019s disease. J Urol. 1995;154(4):1457\u201360.","journal-title":"J Urol"},{"issue":"3","key":"622_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1743-6109.2007.00461.x","volume":"4","author":"A Kadioglu","year":"2007","unstructured":"Kadioglu A, Sanli O, Akman T, Ersay A, Guven S, Mammadov F. Graft materials in Peyronie\u2019s disease surgery: a comprehensive review. J Sex Med. 2007;4(3):581\u201395. doi: 10.1111\/j.1743-6109.2007.00461.x .","journal-title":"J Sex Med"},{"issue":"6","key":"622_CR37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11934-009-0073-0","volume":"10","author":"AC Lentz","year":"2009","unstructured":"Lentz AC, Carson 3rd CC. Peyronie\u2019s surgery: graft choices and outcomes. Curr Urol Rep. 2009;10(6):460\u20137.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"622_CR38","first-page":"15","volume":"60","author":"LD Knoll","year":"1992","unstructured":"Knoll LD, Furlow WL. Corporeal reconstruction and prosthetic implantation for impotence associated with non-dilatable corporeal cavernosal fibrosis. Acta Urol Belg. 1992;60(1):15\u201325.","journal-title":"Acta Urol Belg"},{"issue":"2","key":"622_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsxm.2015.12.011","volume":"13","author":"G Hatzichristodoulou","year":"2016","unstructured":"Hatzichristodoulou G. Partial plaque excision and grafting with collagen fleece in Peyronie disease. J Sex Med. 2016;13(2):277\u201381. doi: 10.1016\/j.jsxm.2015.12.011 .","journal-title":"J Sex Med"},{"issue":"5","key":"622_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ijir.2013.7","volume":"25","author":"G Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Gschwend JE, Lahme S. Surgical therapy of Peyronie\u2019s disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique. Int J Impot Res. 2013;25(5):183\u20137. doi: 10.1038\/ijir.2013.7 .","journal-title":"Int J Impot Res"},{"issue":"9","key":"622_CR41","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1111\/j.1743-6109.2008.00941.x","volume":"5","author":"FL Taylor","year":"2008","unstructured":"Taylor FL, Levine LA. Surgical correction of Peyronie\u2019s disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up. J Sex Med. 2008;5(9):2221\u20138. doi: 10.1111\/j.1743-6109.2008.00941.x . discussion 9\u201330.","journal-title":"J Sex Med"},{"issue":"4","key":"622_CR42","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/01.ju.0000053800.62741.fe","volume":"169","author":"SS Gholami","year":"2003","unstructured":"Gholami SS, Gonzalez-Cadavid NF, Lin CS, Rajfer J, Lue TF. Peyronie\u2019s disease: a review. J Urol. 2003;169(4):1234\u201341. doi: 10.1097\/01.ju.0000053800.62741.fe .","journal-title":"J Urol"},{"issue":"1","key":"622_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrurol.2015.270","volume":"13","author":"L Trost","year":"2016","unstructured":"Trost L, Wanzek P, Bailey G. A practical overview of considerations for penile prosthesis placement. Nat Rev Urol. 2016;13(1):33\u201346. doi: 10.1038\/nrurol.2015.270 .","journal-title":"Nat Rev Urol"},{"issue":"7","key":"622_CR44","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1464-410X.2010.10023.x","volume":"108","author":"G Garaffa","year":"2011","unstructured":"Garaffa G, Minervini A, Christopher NA, Minhas S, Ralph DJ. The management of residual curvature after penile prosthesis implantation in men with Peyronie\u2019s disease. BJU Int. 2011;108(7):1152\u20136. doi: 10.1111\/j.1464-410X.2010.10023.x .","journal-title":"BJU Int"},{"issue":"11","key":"622_CR45","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1111\/j.1743-6109.2010.01971.x","volume":"7","author":"LA Levine","year":"2010","unstructured":"Levine LA, Benson J, Hoover C. Inflatable penile prosthesis placement in men with Peyronie\u2019s disease and drug-resistant erectile dysfunction: a single-center study. J Sex Med. 2010;7(11):3775\u201383. doi: 10.1111\/j.1743-6109.2010.01971.x .","journal-title":"J Sex Med"},{"issue":"6","key":"622_CR46","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jsm.12530","volume":"11","author":"PH Chung","year":"2014","unstructured":"Chung PH, Scott JF, Morey AF. High patient satisfaction of inflatable penile prosthesis insertion with synchronous penile plication for erectile dysfunction and Peyronie\u2019s disease. J Sex Med. 2014;11(6):1593\u20138. 10.1111\/jsm.12530. Important reference: This paper explores combinging plication and IPP placement.","journal-title":"J Sex Med"},{"issue":"1","key":"622_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/jsm.12721","volume":"12","author":"LA Levine","year":"2015","unstructured":"Levine LA, Larsen SM. Surgical correction of persistent Peyronie\u2019s disease following collagenase clostridium histolyticum treatment. J Sex Med. 2015;12(1):259\u201364. doi: 10.1111\/jsm.12721 . Important reference: This paper suggests collagenase administration is not a contraindication to surgical intervention.","journal-title":"J Sex Med"},{"issue":"4 Pt 2","key":"622_CR48","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1743-6109.2007.00537.x","volume":"4","author":"JC LaRochelle","year":"2007","unstructured":"LaRochelle JC, Levine LA. A Survey of primary-care physicians and urologists regarding Peyronie\u2019s disease. J Sex Med. 2007;4(4 Pt 2):1167\u201373. doi: 10.1111\/j.1743-6109.2007.00537.x .","journal-title":"J Sex Med"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-016-0622-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-016-0622-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-016-0622-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T09:00:50Z","timestamp":1568192450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-016-0622-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1007\/s11934-016-0622-2","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]},"article-number":"60"}}